Insulin aspart, recombinant Subcutaneous and Levetiracetam Extended-Release Tablets
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Levetiracetam Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: levetiracetam
Brand name: Keppra, Keppra XR, Roweepra, Spritam, Roweepra XR
Synonyms: Levetiracetam, LevETIRAcetam
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Levetiracetam Injection
- Insulin aspart, recombinant Subcutaneous-Levetiracetam Injection, Concentrate
- Insulin aspart, recombinant Subcutaneous-Levetiracetam Intravenous
- Insulin aspart, recombinant Subcutaneous-Levetiracetam Oral Solution
- Insulin aspart, recombinant Subcutaneous-Levetiracetam Solution
- Insulin aspart, recombinant Subcutaneous-Levetiracetam Tablets
- Levetiracetam Extended-Release Tablets-Insulin degludec
- Levetiracetam Extended-Release Tablets-Insulin Degludec (U-100) Prefilled Pens
- Levetiracetam Extended-Release Tablets-Insulin Degludec (U-100) Vials
- Levetiracetam Extended-Release Tablets-Insulin Degludec (U-200) Prefilled Pens
- Levetiracetam Extended-Release Tablets-Insulin degludec and liraglutide
- Levetiracetam Extended-Release Tablets-Insulin degludec and liraglutide Subcutaneous